In a unanimous decision, the board of Brazil’s federal health regulator Anvisa suspended an exceptional and temporary authorization to import and distribute the Indian-made Covaxin vaccine.
The decision could be reversed if manufacturers produce “new information that allows [regulators] to conclude the legal and technical safety of the vaccine.”Indian lab Bharat Biotech voided its representation contract with Precisa Medicamentos, which is in the middle of a corruption scandal concerning the sale of Covaxin coronavirus vaccines.
Other finalists include the Harvard Business Review, Fortune, Condé Nast, and the NFL
The relationship between farmers and the Luiz Inácio Lula da Silva administration is by no…
Pelé, Ronaldo, Zico, Marta … All of Brazil’s truly immortal sporting icons are footballers, that…
Speaking before a Senate hearing on Tuesday, Chief of Staff Rui Costa admitted that Brazil…
New job market data from the Brazilian Institute of Geography and Statistics (IBGE) show the…
Brazil officially had 5.83 million domestic workers in 2022 — almost the entire population of…